Launched NGS based  breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group.

• ▶Expand precision diagnosis service and dominate the new market

The MP Group is Thailand's leading consignment inspection agency and distributor specializing in medical devices. They held a grand opening event to launch its first NGS service on last January. 
Using NGeneBio’s NGS-based precision diagnosis platform its provide to hospitals, government-affiliated medical institutions, health centers and the general public.

Using NGeneBio’s BRCAaccuTest™PLUS test to identify the BRCA gene which is related to breast cancer and ovarian cancer. The BRCA test service provides -▲analyzes breast BRCA 1/2 gene mutation screening, ▲ an individual's innate breast cancer, ovarian cancer risk, ▲ family history to identify genetic characteristics, ▲and generates personalized gene reports.

NGeneBio representatives also attended and presented the necessity of NGS precision diagnosis and introduced steady seller products .

"Thailand has the largest medical device market among ASEAN countries due to the government's active support and investment in healthcare," said Choi Dae-chul of NGeneBio . "As we have been asked to cooperate in research on genome projects, we will make efforts to expand the Thai market and lead the NGS precision diagnosis market in Southeast Asia."

"BRCAaccuTest PLUS is certified by FDA Thailand, It can be used not only as a diagnostic test for breast cancer target treatment but also as a test for mutation screening of BRCA1/2 genes," Rittichai Srivijarn of MP Group Chairman said. “Based on a friendly relationship with NGeneBio, we plans to expand the BRCA service as well as massively increase the number of joint projects.”